Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial

ConclusionsIn this double-blind randomized trial, we observed the complete remission at 8 weeks in patients with steroid-resistant UC receiving a high dose of AM.Clinical trial registryJAPIC clinical trials information; Japic CTI-205255 (200410115290).https://www.clinicaltrials.jp/cti-user/trial/Search.jsp.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research